CoChat

Targeting the Bacterial Protective Armour; Challenges and Novel Strategies in the Treatment of Microbial Biofilm

Kamaruzzaman, Nor Fadhilah, Tan, Li Peng, Mat Yazid, Khairun Anisa, Saeed, Shamsaldeen Ibrahim, Hamdan, Ruhil Hayati, Choong, Siew Shean, Wong, Weng Kin, Chivu, Alexandru, Gibson, Amanda Jane · 2018 · Materials
Cited by 56

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Infectious disease caused by pathogenic bacteria continues to be the primary challenge to humanity. Antimicrobial resistance and microbial biofilm formation in part, lead to treatment failures. The formation of biofilms by nosocomial pathogens such as Staphylococcus aureus (S. aureus), Pseudomonas aeruginosa (P. aeruginosa), and Klebsiella pneumoniae (K. pneumoniae) on medical devices and on the surfaces of infected sites bring additional hurdles to existing therapies. In this review, we discuss the challenges encountered by conventional treatment strategies in the clinic. We also provide updates on current on-going research related to the development of novel anti-biofilm technologies. We intend for this review to provide understanding to readers on the current problem in health-care settings and propose new ideas for new intervention strategies to reduce the burden related to microbial infections.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ma11091705

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 155

  1. Khan, 2017, Nosocomial infections: Epidemiology, prevention, control and surveillance, Asian Pac. J. Trop. Biomed., 7, 478, 10.1016/j.apjtb.2017.01.019 · DOI · Paper page
  2. Bjarnsholt, 2013, The role of bacterial biofilms in chronic infections, Apmis, 121, 1, 10.1111/apm.12099 · DOI · Paper page
  3. Jiang, 2018, Morbidity and mortality of nosocomial infection after cardiovascular surgery: A report of 1606 cases, Curr. Med. Sci., 38, 329, 10.1007/s11596-018-1883-4 · doi:10.1007/s11596-018-1883-4
  4. 2017, Impact on morbidity, mortality and length of stay of hospital acquired infections by resistant microorganisms, Clin. Infect. Dis., 65, 644, 10.1093/cid/cix411 · DOI · Paper page
  5. Klevens, 2007, Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002, Public Health Rep., 122, 160, 10.1177/003335490712200205 · DOI · Paper page
  6. Chopra, 2008, Treatment of health-care-associated infections caused by Gram-negative bacteria: A consensus statement, Lancet Infect. Dis., 8, 133, 10.1016/S1473-3099(08)70018-5 · DOI · Paper page
  7. Dufrene, 2018, Force matters in hospital-acquired infections, Science, 359, 1464, 10.1126/science.aat3764 · DOI
  8. Mataraci, 2012, In vitro activities of antibiotics and antimicrobial cationic peptides alone and in combination against methicillin-resistant Staphylococcus aureus biofilms, Antimicrob. Agents Chemother., 56, 6366, 10.1128/AAC.01180-12 · DOI
  9. Percival, 2015, Healthcare-Associated infections, medical devices and biofilms: Risk, tolerance and control, J. Med. Microbiol., 64, 323, 10.1099/jmm.0.000032 · DOI · Paper page
  10. Yean, 2010, Methicillin-resistant Staphylococcus aureus nosocomial infection trends in Hospital Universiti Sains Malaysia during 2002–2007, Ann. Saudi Med., 30, 358, 10.4103/0256-4947.67077 · DOI
  11. Macmorran, 2017, The rise of methicillin resistant Staphylococcus aureus: Now the dominant cause of skin and soft tissue infection in Central Australia, Epidemiol. Infect., 145, 2817, 10.1017/S0950268817001716 · DOI
  12. Enright, 2002, The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA), Proc. Natl. Acad. Sci. USA, 99, 7687, 10.1073/pnas.122108599 · DOI · Paper page
  13. Malani, 2014, National burden of invasive methicillin-resistant Staphylococcus aureus infection, JAMA, 311, 1438, 10.1001/jama.2014.1666 · DOI
  14. Sisirak, 2010, Methicillin-resistant Staphylococcus aureus (MRSA) as a cause of nosocomial wound infections, Bosn. J. Basic Med. Sci., 10, 32, 10.17305/bjbms.2010.2733 · doi:10.17305/bjbms.2010.2733
  15. Kamaruzzaman, 2016, Bactericidal effects of polyhexamethylene biguanide against intracellualar Staphylococcus aureus EMRSA-15 and USA 300, J. Antimicrob. Chemother., 71, 1252, 10.1093/jac/dkv474 · DOI
  16. Zhou, 2010, Diagnosis and management of complicated intra-abdominal infection in adults and children: Guidelines by the surgical infection society and the infectious diseases society of America, Chin. J. Infect. Chemother., 10, 241
  17. Codjoe, F., and Donkor, E. (2017). Carbapenem Resistance: A Review. Med. Sci., 6. · DOI · Paper page
  18. Johansen, 2008, Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients, J. Cyst. Fibros., 7, 391, 10.1016/j.jcf.2008.02.003 · DOI · Paper page
  19. Criss, 2009, Resistance of Neisseria gonorrhoeae to non-oxidative killing by adherent human polymorphonuclear leucocytes, Cell. Microbiol., 11, 1074, 10.1111/j.1462-5822.2009.01308.x · DOI · Paper page
  20. Fiaccadori, 2016, Colistin Use in Patients With Reduced Kidney Function, Am. J. Kidney Dis., 68, 296, 10.1053/j.ajkd.2016.03.421 · DOI
  21. Chatterjee, 2016, Antibiotic resistance in Pseudomonas aeruginosa and alternative therapeutic options, Int. J. Med. Microbiol., 306, 48, 10.1016/j.ijmm.2015.11.004 · DOI · Paper page
  22. 2015, The impact of hospital-acquired infections with multidrug-resistant bacteria in an oncology intensive care unit, Int. J. Infect. Dis., 31, 31, 10.1016/j.ijid.2014.12.022 · DOI · Paper page
  23. Golan, 2015, Empiric therapy for hospital-acquired, Gram-negative complicated intra-abdominal infection and complicated urinary tract infections: A systematic literature review of current and emerging treatment options, BMC Infect. Dis., 15, 1, 10.1186/s12879-015-1054-1 · DOI
  24. Yayan, 2015, Antibiotic resistance of Pseudomonas aeruginosa in pneumonia at a single university hospital center in Germany over a 10-Year Period, PLoS ONE, 10, 1, 10.1371/journal.pone.0139836 · DOI · Paper page
  25. Jamal, 2018, Bacterial biofilm and associated infections, J. Chin. Med. Assoc., 81, 7, 10.1016/j.jcma.2017.07.012 · DOI · Paper page
  26. Mcguffie, 2016, σ factor and anti-σ factor that control swarming motility and biofilm formation in Pseudomonas aeruginosa, J. Bacteriol., 198, 755, 10.1128/JB.00784-15 · DOI
  27. Chaftari, 2014, The use of minocycline-rifampin coated central venous catheters for exchange of catheters in the setting of Staphylococcus aureus central line associated bloodstream infections, BMC Infect. Dis., 14, 1, 10.1186/1471-2334-14-518 · doi:10.1186/1471-2334-14-518
  28. Paczosa, 2016, Klebsiella pneumoniae: Going on the offense with a strong defense, Microbiol. Mol. Biol. Rev., 80, 629, 10.1128/MMBR.00078-15 · DOI · Paper page
  29. Livermore, 2013, Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases, Lancet Infect. Dis., 13, 785, 10.1016/S1473-3099(13)70190-7 · DOI · Paper page
  30. Otter, 2017, Emergence and clonal spread of colistin resistance due to multiple mutational mechanisms in carbapenemase-producing Klebsiella pneumoniae in London, Sci. Rep., 7, 1, 10.1038/s41598-017-12637-4 · DOI
  31. Singla, 2014, Artificial Klebsiella pneumoniae biofilm model mimicking in vivo system: Altered morphological characteristics and antibiotic resistance, J. Antibiot., 67, 305, 10.1038/ja.2013.139 · DOI
  32. Chung, 2016, The emerging problems of Klebsiella pneumoniae infections: Carbapenem resistance and biofilm formation, FEMS Microbiol. Lett., 363, 1, 10.1093/femsle/fnw219 · DOI
  33. Jendresen, 1981, Clinical adhesiveness of selected dental materials: An in-vivo study, Acta Odontol. Scand., 39, 39, 10.3109/00016358109162257 · DOI
  34. 2014, A personal history of research on microbial biofilms and biofilm infections, Pathog. Dis., 70, 205, 10.1111/2049-632X.12165 · DOI
  35. Werner, 2004, Stratified growth in Pseudomonas aeruginosa biofilms stratified growth in Pseudomonas aeruginosa biofilms, Appl. Environ. Microbiol., 70, 6188, 10.1128/AEM.70.10.6188-6196.2004 · DOI · Paper page
  36. Kamaruzzaman, 2017, Bactericidal and anti-biofilm effects of polyhexamethylene Biguanide in models of intracellular and biofilm of Staphylococcus aureus isolated from bovine mastitis, Front. Microbiol., 8, 1, 10.3389/fmicb.2017.01518 · DOI
  37. Czaczyk, 2007, Biosynthesis of extracellular polymeric substances (EPS) and its role in microbial biofilm formation, Pol. J. Environ. Stud., 16, 799
  38. Billings, N., Ramirez Millan, M., Caldara, M., Rusconi, R., Tarasova, Y., Stocker, R., and Ribbeck, K. (2013). The extracellular matrix component Psl provides fast-acting antibiotic defense in Pseudomonas aeruginosa biofilms. PLoS Pathog., 9. · DOI · Paper page
  39. Jennings, 2015, Pel is a cationic exopolysaccharide that cross-links extracellular DNA in the Pseudomonas aeruginosa biofilm matrix, Proc. Natl. Acad. Sci. USA, 112, 11353, 10.1073/pnas.1503058112 · DOI · Paper page
  40. Das, 2014, Influence of calcium in extracellular DNA mediated bacterial aggregation and biofilm formation, PLoS ONE, 9, 1
  41. Okshevsky, 2013, The role of extracellular DNA in the establishment, maintenance and perpetuation of bacterial biofilms, Crit. Rev. Microbiol., 41, 1
  42. Montanaro, 2011, Extracellular DNA in biofilms, Int. J. Artif. Organs, 34, 824, 10.5301/ijao.5000051 · DOI · Paper page
  43. Davies, 1998, The involvement of cell-to-cell signals in the development of a bacterial biofilm, Science, 280, 295, 10.1126/science.280.5361.295 · DOI · Paper page
  44. Braga, 2016, Microbial interactions: Ecology in a molecular perspective, Braz. J. Microbiol., 47, 86, 10.1016/j.bjm.2016.10.005 · DOI · Paper page
  45. Costerton, 2011, Bacterial Biofilms: A Common Cause of Persistent Infections, Science, 284, 1318, 10.1126/science.284.5418.1318 · DOI · Paper page
  46. Stewart, 2008, Physiological heterogeneity in biofilms, Nat. Rev. Microbiol., 6, 199, 10.1038/nrmicro1838 · DOI · Paper page
  47. La, 1987, Method of evaluating effects of antibiotics on bacterial biofilm, Antimicrob. Agents Chemother., 31, 1502, 10.1128/AAC.31.10.1502 · DOI · Paper page
  48. Nickel, 1985, Tobramycin resistance of cells of Pseudomonas aeruginosa growing as biofilm on urinary catheter material, Antimicrob. Agents Chemother., 27, 619, 10.1128/AAC.27.4.619 · DOI · Paper page
  49. Singh, 2016, Penetration barrier contributes to bacterial biofilm-associated resistance against only select antibiotics, and exhibits genus-, strain- and antibiotic-specific differences, Pathog. Dis., 74, 1, 10.1093/femspd/ftw056 · DOI
  50. Nguyen, 2011, Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria, Science, 334, 982, 10.1126/science.1211037 · DOI · Paper page
  51. Bowler, 2012, Mature Pseudomonas aeruginosa biofilms prevail compared to young biofilms in the presence of ceftazidime, Antimicrob. Agents Chemother., 56, 4976, 10.1128/AAC.00650-12 · DOI
  52. Johnson, L., Horsman, S.R., Charron-Mazenod, L., Turnbull, A.L., Mulcahy, H., Surette, M.G., and Lewenza, S. (2013). Extracellular DNA-induced antimicrobial peptide resistance in Salmonella enterica serovar Typhimurium. BMC Microbiol., 13. · DOI
  53. Walters, 2003, Contributions of Antibiotic Penetration, Oxygen Limitation, Antimicrob. Agents Chemother., 47, 317, 10.1128/AAC.47.1.317-323.2003 · DOI · Paper page
  54. Borriello, 2004, Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms, Antimicrob. Agents Chemother., 48, 2659, 10.1128/AAC.48.7.2659-2664.2004 · DOI · Paper page
  55. Stewart, 2015, Contribution of stress responses to antibiotic tolerance in Pseudomonas aeruginosa biofilms, Antimicrob. Agents Chemother., 59, 3838, 10.1128/AAC.00433-15 · DOI
  56. Waters, 2016, Convergence of Staphylococcus aureus persister and biofilm research: Can biofilms be defined as communities of adherent persister cells?, PLoS Pathog., 12, 2, 10.1371/journal.ppat.1006012 · DOI · Paper page
  57. Le, 2018, Immune evasion mechanisms of Staphylococcus epidermidis biofilm infection, Front. Microbiol., 9, 1, 10.3389/fmicb.2018.00359 · DOI
  58. Roilides, E., Simitsopoulou, M., Katragkou, A., and Walsh, T.J. (2015). How Biofilms Evade Host Defenses. Microbial Biofilms, American Society for Microbiology. [2nd ed.]. · DOI
  59. Leid, 2002, Human leukocytes adhere to, penetrate, and respond to Staphylococcus aureus biofilms, Infect. Immun., 70, 6339, 10.1128/IAI.70.11.6339-6345.2002 · DOI · Paper page
  60. Jesaitis, 2003, Compromised host defense on Pseudomonas aeruginosa biofilms: Characterization of neutrophil and biofilm interactions, J. Immunol., 171, 4329, 10.4049/jimmunol.171.8.4329 · DOI · Paper page
  61. Jensen, 1990, Human polymorphonuclear leukocyte response to Pseudomonas aeruginosa grown in biofilms, Infect. Immun., 58, 2383, 10.1128/iai.58.7.2383-2385.1990 · DOI · Paper page
  62. Bjarnsholt, 2015, ESCMID* guideline for the diagnosis and treatment of biofilm infections 2014, Clin. Microbiol. Infect., 21, S1, 10.1016/j.cmi.2014.10.024 · DOI · Paper page
  63. Guinea, 2018, Microbiological diagnosis of biofilm-related infections, Enferm. Infecc. Microbiol. Clin., 36, 375
  64. Almani, 2017, Detection of biofilm-associated implant pathogens in cardiac device infections: High sensitivity of sonication fluid culture even in the presence of antimicrobials, J. Glob. Infect. Dis., 9, 135
  65. Mandakhalikar, 2018, Extraction and quantification of biofilm bacteria: Method optimized for urinary catheters, Sci. Rep., 8, 1, 10.1038/s41598-018-26342-3 · doi:10.1038/s41598-018-26342-3
  66. Renz, 2018, Value of PCR in sonication fluid for the diagnosis of orthopedic hardware-associated infections: Has the molecular era arrived?, Injury, 49, 806, 10.1016/j.injury.2018.02.018 · doi:10.1016/j.injury.2018.02.018
  67. Schuurs, T.A., Koelewijn, R., Brienen, E.A.T., Kortbeek, T., Mank, T.G., Mulder, B., Stelma, F.F., Van Lieshout, L., and Van Hellemond, J.J. (2018). Harmonization of PCR-based detection of intestinal pathogens: Experiences from the Dutch external quality assessment scheme on molecular diagnosis of protozoa in stool samples. Clin. Chem. Lab. Med., 1–6. · DOI
  68. Stavnsbjerg, 2017, Comparison of two commercial broad-range PCR and sequencing assays for identification of bacteria in culture-negative clinical samples, BMC Infect. Dis., 17, 1, 10.1186/s12879-017-2333-9 · DOI
  69. Morio, 2018, PCR-based detection of Aspergillus fumigatus and absence of azole resistance due to TR34/L98H in a french multicenter cohort of 137 patients with fungal rhinosinusitis, Mycoses, 61, 30, 10.1111/myc.12702 · DOI
  70. Davis, L.E., and Tyler, K.L. (2005). Molecular Diagnosis of CNS Viral Infections, Elsevier Inc. · DOI
  71. Bizzini, 2010, Matrix-assisted laser desorption ionization time-of-flight mass spectrometry, a revolution in clinical microbial identification, Clin. Microbiol. Infect., 16, 1614, 10.1111/j.1469-0691.2010.03311.x · DOI · Paper page
  72. Kliem, 2012, The essence on mass spectrometry based microbial diagnostics, Curr. Opin. Microbiol., 15, 397, 10.1016/j.mib.2012.02.006 · DOI
  73. Gaudreau, 2018, Evaluation of MALDI-TOF mass spectrometry for the identification of bacteria growing as biofilms, J. Microbiol. Methods, 145, 79, 10.1016/j.mimet.2018.01.003 · DOI
  74. Frickmann, 2017, Fluorescence in situ hybridization (FISH) in the microbiological diagnostic routine laboratory: A review, Crit. Rev. Microbiol., 43, 263, 10.3109/1040841X.2016.1169990 · DOI · Paper page
  75. Eickhardt, 2018, Morphological evidence of biofilm in chronic obstructive sialadenitis, J. Laryngol. Otol., 132, 1
  76. Wunder, 2007, The in vivo dynamics of Streptococcus spp., Actinomyces naeslundii, Fusobacterium nucleatum and Veillonella spp. in dental plaque biofilm as analysed by five-colour multiplex fluorescence in situ hybridization, J. Med. Microbiol., 56, 681, 10.1099/jmm.0.47094-0 · DOI · Paper page
  77. Hardy, 2015, Unravelling the bacterial vaginosis-associated biofilm: A multiplex Gardnerella vaginalis and Atopobium vaginae fluorescence in situ hybridization assay using peptide nucleic acid probes, PLoS ONE, 10, 1, 10.1371/journal.pone.0136658 · DOI · Paper page
  78. Hu, 2015, Intensive care unit environmental surfaces are contaminated by multidrug-resistant bacteria in biofilms: Combined results of conventional culture, pyrosequencing, scanning electron microscopy, and confocal laser microscopy, J. Hosp. Infect., 91, 35, 10.1016/j.jhin.2015.05.016 · DOI · Paper page
  79. Mohmmed, 2017, Confocal laser scanning, scanning electron, and transmission electron microscopy investigation of Enterococcus faecalis biofilm degradation using passive and active sodium hypochlorite irrigation within a simulated root canal model, Microbiologyopen, 6, 1, 10.1002/mbo3.455 · DOI
  80. Tani, 2018, Superiority of the sonication method against conventional periprosthetic tissue cultures for diagnosis of prosthetic joint infections, Eur. J. Orthop. Surg. Traumatol., 28, 51, 10.1007/s00590-017-2012-y · doi:10.1007/s00590-017-2012-y
  81. Hayes, 2006, Direct Detection of Bacterial Biofilms on the Middle-Ear Mucosa of Children, JAMA, 296, 202, 10.1001/jama.296.2.202 · DOI · Paper page
  82. Renz, 2017, Performance of automated multiplex PCR using sonication fluid for diagnosis of periprosthetic joint infection: A prospective cohort, Infection, 45, 877, 10.1007/s15010-017-1073-5 · doi:10.1007/s15010-017-1073-5
  83. Boase, 2013, The microbiome of chronic rhinosinusitis: Culture, molecular diagnostics and biofilm detection, BMC Infect. Dis., 13, 1, 10.1186/1471-2334-13-210 · DOI · Paper page
  84. Bjarnsholt, 2013, Applying insights from biofilm biology to drug development-can a new approach be developed?, Nat. Rev. Drug Discov., 12, 791, 10.1038/nrd4000 · DOI · Paper page
  85. Escribano, 2015, Spanish Consensus on the Prevention and Treatment of Pseudomonas aeruginosa Bronchial Infections in Cystic Fibrosis Patients, Arch. Bronconeumol., 51, 140, 10.1016/j.arbr.2014.09.018 · DOI
  86. Haworth, 2014, Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection, Am. J. Respir. Crit. Care Med., 189, 975, 10.1164/rccm.201312-2208OC · DOI · Paper page
  87. Wilson, 2013, Ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis: A phase II randomised study, Eur. Respir. J., 41, 1107, 10.1183/09031936.00071312 · DOI · Paper page
  88. Ezzat, 2015, Effect of topical ofloxacin on bacterial biofilms in refractory post-sinus surgery rhino-sinusitis, Eur. Arch. Oto-Rhino-Laryngol., 272, 2355, 10.1007/s00405-014-3301-2 · doi:10.1007/s00405-014-3301-2
  89. Kaiser, 2014, An in vitro analysis of the effects of various topical antimicrobial agents on methicillin-resistant and methicillin-sensitive strains of Staphylococcus aureus, Ostomy Wound Manag., 60, 18
  90. Hogan, 2016, In vitro approach for identification of the most effective agents for antimicrobial lock therapy in the treatment of intravascular catheter-related infections caused by Staphylococcus aureus, Antimicrob. Agents Chemother., 60, 2923, 10.1128/AAC.02885-15 · DOI
  91. Moghaddas, 2015, Prevention of hemodialysis catheter-related blood stream infections using a cotrimoxazole-lock technique, Future Microbiol., 10, 169, 10.2217/fmb.14.116 · DOI
  92. 2018, Investigation of the effects of various antibiotics against Klebsiella pneumoniae biofilms on in vitro catheter model, J. Chemother., 30, 82, 10.1080/1120009X.2017.1390633 · DOI
  93. Krajewski, 2014, Successful treatment of extensively drug-resistant Pseudomonas aeruginosa osteomyelitis using a colistin- and tobramycin-impregnated PMMA spacer, Int. J. Antimicrob. Agents, 44, 363, 10.1016/j.ijantimicag.2014.05.023 · DOI
  94. Cancienne, 2015, Applications of Local Antibiotics in Orthopedic Trauma, Orthop. Clin. N. Am., 46, 495, 10.1016/j.ocl.2015.06.010 · DOI
  95. Khodakovskaya, C.K.S.K.V. (2016). Plant Nanotechnology: Principles and Practices, Springer International Publishing.
  96. Yadav, 2017, Graphene oxide-coated surface: Inhibition of bacterial biofilm formation due to specific surface-interface interactions, ACS Omega, 2, 3070, 10.1021/acsomega.7b00371 · DOI
  97. Hajipour, 2012, Antibacterial properties of nanoparticles, Trends Biotechnol., 30, 499, 10.1016/j.tibtech.2012.06.004 · DOI · Paper page
  98. Aditya, 2018, Zinc Oxide nanoparticles dispersed in ionic liquids show high antimicrobial efficacy to skin-specific bacteria, ACS Appl. Mater. Interfaces, 10, 15401, 10.1021/acsami.8b01463 · doi:10.1021/acsami.8b01463
  99. Coenye, 2017, The Role of Reactive Oxygen species in antibiotic-mediated killing of bacteria, Trends Microbiol., 25, 456, 10.1016/j.tim.2016.12.008 · DOI · Paper page
  100. Chindera, 2016, The antimicrobial polymer PHMB enters cells and selectively condenses bacterial chromosomes, Sci. Rep., 6, 23121, 10.1038/srep23121 · DOI · Paper page
  101. Qin, 2014, In vitro and in vivo anti-biofilm effects of silver nanoparticles immobilized on titanium, Biomaterials, 35, 9114, 10.1016/j.biomaterials.2014.07.040 · DOI · Paper page
  102. Abdulkareem, 2015, Anti-biofilm activity of zinc oxide and hydroxyapatite nanoparticles as dental implant coating materials, J. Dent., 43, 1462, 10.1016/j.jdent.2015.10.010 · DOI · Paper page
  103. Allaker, 2010, Critical review in oral biology & medicine: The use of nanoparticles to control oral biofilm formation, J. Dent. Res., 89, 1175, 10.1177/0022034510377794 · DOI · Paper page
  104. Gurunathan, 2014, Enhanced antibacterial and anti-biofilm activities of silver nanoparticles against Gram-negative and Gram-positive bacteria, Nanoscale Res. Lett., 9, 1, 10.1186/1556-276X-9-373 · DOI · Paper page
  105. Jalvo, 2017, Antimicrobial and antibiofilm efficacy of self-cleaning surfaces functionalized by TiO2 photocatalytic nanoparticles against Staphylococcus aureus and Pseudomonas putida, J. Hazard. Mater., 340, 160, 10.1016/j.jhazmat.2017.07.005 · DOI · Paper page
  106. Shakibaie, 2015, Anti-biofilm activity of biogenic selenium nanoparticles and selenium dioxide against clinical isolates of Staphylococcus aureus, Pseudomonas aeruginosa, and Proteus mirabilis, J. Trace Elem. Med. Biol., 29, 235, 10.1016/j.jtemb.2014.07.020 · DOI · Paper page
  107. Tchimene, M.K., Okunji, C.O., Iwu, M.M., and Kuete, V. (2013). Monoterpenes and Related Compounds from the Medicinal Plants of Africa. Medicinal Plant Research in Africa, Elsevier. · doi:10.1016/b978-0-12-405927-6.00001-1
  108. Manner, 2015, New derivatives of dehydroabietic acid target planktonic and biofilm bacteria in Staphylococcus aureus and effectively disrupt bacterial membrane integrity, Eur. J. Med. Chem., 102, 68, 10.1016/j.ejmech.2015.07.038 · DOI
  109. Walencka, 2007, Antimicrobial activity of diterpenoids from hairy roots of Salvia sclarea L.: Salvipisone as a potential anti-biofilm agent active against antibiotic resistant Staphylococci, Phytomedicine, 14, 31, 10.1016/j.phymed.2005.10.008 · DOI · Paper page
  110. Nowakowska, 2013, Antimicrobial properties of 8-hydroxyserrulat-14-en-19-oic acid for treatment of implant-associated infections, Antimicrob. Agents Chemother., 57, 333, 10.1128/AAC.01735-12 · DOI
  111. Tan, 2017, Broad Spectrum Macromolecular Antimicrobials with Biofilm Disruption Capability and In Vivo Efficacy, Adv. Healthc. Mater., 6, 1, 10.1002/adhm.201601420 · DOI
  112. Nadell, 2016, Spatial structure, cooperation and competition in biofilms, Nat. Rev. Microbiol., 14, 589, 10.1038/nrmicro.2016.84 · DOI · Paper page
  113. Donlan, 2001, Biofilms and device-associated infections, Emerg. Infect. Dis., 7, 277, 10.3201/eid0702.010226 · DOI · Paper page
  114. Dos Santos Goncalves, M., Delattre, C., Balestrino, D., Charbonnel, N., Elboutachfaiti, R., Wadouachi, A., Badel, S., Bernardi, T., Michaud, P., and Forestier, C. (2014). Anti-biofilm activity: A function of Klebsiella pneumoniae capsular polysaccharide. PLoS ONE, 9. · DOI
  115. Molmeret, 2016, Characterization and anti-biofilm activity of extracellular polymeric substances produced by the marine biofilm-forming bacterium pseudoalteromonas ulvae strain TC14, Biofouling, 32, 547, 10.1080/08927014.2016.1164845 · DOI
  116. Augustine, 2010, Inhibition of Vibrio cholerae biofilm by AiiA enzyme produced from Bacillus spp, Arch. Microbiol., 192, 1019, 10.1007/s00203-010-0633-1 · doi:10.1007/s00203-010-0633-1
  117. Pande, 2018, Anti-bacterial and anti-biofilm activity of commercial organic acid products against Salmonella enterica isolates recovered from an egg farm environment, Avian Pathol., 47, 189, 10.1080/03079457.2017.1394979 · DOI
  118. Francolini, 2010, Prevention and control of biofilm-based medical-device-related infections, FEMS Immunol. Med. Microbiol., 59, 227, 10.1111/j.1574-695X.2010.00665.x · DOI · Paper page
  119. Cooper, 2014, Honey as an effective antimicrobial treatment for chronic wounds: Is there a place for it in modern medicine?, Chronic Wound Care Manag. Res., 1, 15, 10.2147/CWCMR.S46520 · DOI
  120. Simon, 2009, Medical honey for wound carestill the latest resort, Evid.-Based Complement. Altern. Med., 6, 165, 10.1093/ecam/nem175 · DOI · Paper page
  121. Biglari, 2013, Medical honey in professional wound care, Expert Rev. Dermatol., 8, 51, 10.1586/edm.12.66 · DOI
  122. Watts, 2017, Evidence Summary: Wound management: Medical-grade honey, Wound Pract. Res., 25, 117
  123. Alber, 2013, Synergism between Medihoney and Rifampicin against Methicillin-Resistant Staphylococcus aureus (MRSA), PLoS ONE, 8, 1
  124. Liu, 2018, Rifampicin-manuka honey combinations are superior to other antibiotic-manuka honey combinations in eradicating Staphylococcus aureus biofilms, Front. Microbiol., 8, 1, 10.3389/fmicb.2017.02653 · DOI
  125. Liu, 2014, Antibiotic-specific differences in the response of Staphylococcus aureus to treatment with antimicrobials combined with manuka honey, Front. Microbiol., 5, 1
  126. Paramasivan, 2014, Methylglyoxal-augmented manuka honey as a topical anti-Staphylococcus aureus biofilm agent: Safety and efficacy in an in vivo model, Int. Forum Allergy Rhinol., 4, 187, 10.1002/alr.21264 · DOI · Paper page
  127. Amer, 2017, Honey-based hydrogel: In vitro and comparative in vivo evaluation for burn wound healing, Sci. Rep., 7, 1
  128. Lu, J., Carter, D.A., Turnbull, L., Rosendale, D., Hedderley, D., Stephens, J., Gannabathula, S., Steinhorn, G., Schlothauer, R.C., and Whitchurch, C.B. (2013). The Effect of New Zealand Kanuka, Manuka and Clover The effect of New Zealand kanuka, manuka and clover honeys on bacterial growth dynamics and cellular morphology varies according to the species. PLoS ONE, 8. · DOI
  129. Abbas, 2014, Comparative Antibacterial and Antibiofilm Activities of Manuka Honey and Egyptian Clover Honey, Asian J. Appl. Sci., 2, 110
  130. Majtan, 2014, Anti-biofilm effects of honey against wound pathogens proteus mirabilis and enterobacter cloacae, Phyther. Res., 28, 69, 10.1002/ptr.4957 · DOI
  131. Campeau, 2014, Antibiofilm Activity of Manuka Honey in Combination with Antibiotics, Int. J. Bacteriol., 2014, 1, 10.1155/2014/795281 · DOI · Paper page
  132. Wang, 2015, In-vitro Activity of Honey and Topical Silver in Wound Care Management, Drug Res., 65, 592
  133. Sojka, 2016, Antibiofilm efficacy of honey and bee-derived defensin-1 on multispecies wound biofilm, J. Med. Microbiol., 65, 337, 10.1099/jmm.0.000227 · DOI
  134. Halstead, 2017, Use of an engineered honey to eradicate preformed biofilms of important wound pathogens: An in vitro study, J. Wound Care, 26, 442, 10.12968/jowc.2017.26.8.442 · DOI
  135. Piotrowski, 2017, Antimicrobial effects of Manuka honey on in vitro biofilm formation by Clostridium difficile, Eur. J. Clin. Microbiol. Infect. Dis., 36, 1661, 10.1007/s10096-017-2980-1 · DOI
  136. Emineke, 2017, Diluted honey inhibits biofilm formation: Potential application in urinary catheter management?, J. Clin. Pathol., 70, 140, 10.1136/jclinpath-2015-203546 · DOI
  137. Lu, 2014, Manuka-type honeys can eradicate biofilms produced by Staphylococcus aureus strains with different biofilm-forming abilities, PeerJ, 2, e326, 10.7717/peerj.326 · DOI
  138. Ceylan, O., Ugur, A., Isiloglu, M., and Ozcan, F. (October, January 29). Evaluatıon of the Antıbacterıal, Antıbıofılm, Antıoxıdant, and Cytotoxıc Effects of Some Turkısh Honeys. Proceedings of the XXXXIII International Apicultural Congres, Kyiv, Ukraine.
  139. Aissat, 2016, Propolis-Sahara honeys preparation exhibits antibacterial and anti-biofilm activity against bacterial biofilms formed on urinary catheters, Asian Pac. J. Trop. Dis., 6, 873, 10.1016/S2222-1808(16)61149-0 · DOI
  140. Aazza, 2016, Propiedades antibacterianas, anti-biofilm, anti-inflamatorias y de inhibición de la virulencia de mieles portuguesas, J. Apic. Res., 55, 292, 10.1080/00218839.2016.1243294 · DOI
  141. Hancock, 2006, Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies, Nat. Biotechnol., 24, 1551, 10.1038/nbt1267 · DOI · Paper page
  142. Ganz, 1999, Antibiotic peptides from higher eukaryotes: Biology and applications, Mol. Med. Today, 5, 292, 10.1016/S1357-4310(99)01490-2 · DOI · Paper page
  143. Batoni, 2016, Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria, Biochim. Biophys. Acta -Biomembr., 1858, 1044, 10.1016/j.bbamem.2015.10.013 · DOI · Paper page
  144. Pletzer, 2016, Anti-biofilm peptides: Potential as broad-spectrum agents, J. Bacteriol., 198, 2572, 10.1128/JB.00017-16 · DOI · Paper page
  145. Chung, 2017, Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria, J. Microbiol. Immunol. Infect., 50, 405, 10.1016/j.jmii.2016.12.005 · DOI · Paper page
  146. Zasloff, 2002, Antimicrobial peptides of multicellular organisms, Nature, 415, 389, 10.1038/415389a · DOI · Paper page
  147. Wang, 2015, High specific selectivity and Membrane-Active Mechanism of the synthetic centrosymmetric α-helical peptides with Gly-Gly pairs, Sci. Rep., 5, 1
  148. Cardoso, 2016, Synthetic antibiofilm peptides, Biochim. Biophys. Acta -Biomembr., 1858, 1061, 10.1016/j.bbamem.2015.12.015 · DOI · Paper page
  149. Maccari, 2015, BaAMPs: The database of biofilm-active antimicrobial peptides, Biofouling, 31, 193, 10.1080/08927014.2015.1021340 · DOI · Paper page
  150. Takahashi, 2017, Cationic amphiphilic polymers with antimicrobial activity for oral care applications: Eradication of S. mutans biofilm, Biomacromolecules, 181, 257, 10.1021/acs.biomac.6b01598 · DOI
  151. Peng, C., Vishwakarma, A., Li, Z., Miyoshi, T., Barton, H., and Joy, A. (2018). Modification of a conventional polyurethane composition provides significant anti-biofilm activity against Escherichia coli. Polym. Chem., 776. · doi:10.1039/c8py00492g
  152. Kaehn, 2010, Polihexanide: A safe and highly effective biocide, Skin Pharmacol. Physiol., 23, 7, 10.1159/000318237 · doi:10.1159/000318237
  153. Kamaruzzaman, N.F., Pina, M.D.F., Chivu, A., and Good, L. (2018). Polyhexamethylene biguanide and nadifloxacin self-assembled nanoparticles: Antimicrobial effects against intracellular methicillin-resistant Staphylococcus aureus. Polymers (Basel), 10. · DOI
  154. Lefebvre, 2018, Ephemeral biogels to control anti-biofilm agent delivery: From conception to the construction of an active dressing, Mater. Sci. Eng. C, 82, 210, 10.1016/j.msec.2017.07.044 · DOI
  155. Cutting, 2010, Addressing the challenge of wound cleansing in the modern era, Br. J. Nurs., 19, S24, 10.12968/bjon.2010.19.Sup4.48423 · DOI

Cited by

See all 56

Metadata

Authors
Kamaruzzaman, N. F., Tan, L. P., Mat Yazid, K. A., Saeed, S. I., Hamdan, R. H., Choong, S. S., Wong, W. K., Chivu, A., & Gibson, A. J.
Affiliations
  • Faculty of Veterinary Medicine, Universiti Malaysia Kelantan, Pengkalan Chepa 16100, Kelantan, Malaysia
  • School of Health Sciences, Universiti Sains Malaysia, Kubang Kerian 16150, Kelantan, Malaysia
  • UCL Centre for Nanotechnology and Regenerative Medicine, Division of Surgery & Interventional Science, University College London, London NW3 2PF, UK
  • Royal Veterinary College, Pathobiology and Population Sciences, Hawkshead Lane, North Mymms, Hatfield AL9 7TA, UK
Venue
Materials
Publisher
MDPI AG
Published
2018-09-13
Volume
11
Issue
9
Pages
1705
ISSN
1996-1944
Cited by
56
References
13
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.